194 filings
Page 4 of 10
POS AM
c67s0lr
25 Aug 23
Prospectus update (post-effective amendment)
5:00pm
6-K/A
o618 0hrgbc
18 Aug 23
Evaxion Announces Business Update and Second Quarter 2023 Financial Results
9:28am
6-K
l58zqnqtw7x5b2yyk
17 Aug 23
Current report (foreign)
4:58pm
6-K
6ljvj2yb3244z9
17 Aug 23
Evaxion Announces Business Update and Second Quarter 2023 Financial Results
4:45pm
6-K
kp16ri9p1ah
11 Aug 23
Current report (foreign)
4:45pm
6-K
ei8vs5 viq
4 Aug 23
Current report (foreign)
4:45pm
6-K
pfmwrq7fauc0f6s
1 Aug 23
Evaxion announces financing commitments totaling up to USD 20 million with Negma Group
7:00am
6-K
z3pgkaxcrylqtb lkb7
31 Jul 23
Current report (foreign)
4:45pm
6-K
rra3p87aplv8z
31 Jul 23
Evaxion presents promising results on EVX-B1, an AI-designed vaccine against Staphylococcus aureus
7:00am
6-K
nyygw8jrr952cs3vmgf
11 Jul 23
Current report (foreign)
9:14am
6-K
6b3l6c6x066s vh
5 Jun 23
Current report (foreign)
8:32am
6-K
wvca6qpxk19suhj0
5 Jun 23
Current report (foreign)
7:44am
6-K
g6e9mxv046j8baylbar
31 May 23
Evaxion Announces Business Update and First Quarter 2023 Financial Results
8:36am
6-K
3xjjs
25 May 23
Evaxion unveils proprietary genetic adjuvant technology to boost the effect of DNA and mRNA vaccines
4:55pm
6-K
ue7zcejfdqhg
25 May 23
Evaxion announces promising clinical Phase 1 data
4:55pm
6-K
vy7o4ei1wzrv fo8u8
4 May 23
Notice of Annual General Meeting
4:45pm
6-K
j3ikx
27 Apr 23
Fourth quarter and full year 2022 financial results and business update
8:30am
6-K
stsgg01nijvj
18 Apr 23
Current report (foreign)
9:19am
6-K
ldp4perla26
18 Apr 23
Current report (foreign)
8:00am